Pre-order Enquiry
Request Free Sample
Global Clinical Oncology Next Generation Sequencing (NGS) Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14461005 | Publishing Date : 19-Jul-2019 | No. of pages : 104
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Clinical Oncology Next Generation Sequencing (NGS) Market Size, Status and Forecast 2019-2025
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Type (2014-2025)
1.4.2 NGS Pre-Sequencing
1.4.3 Sequencing
1.4.4 NGS Data Analysis
1.4.5 Primary, Secondary & Tertiary Data Analysis
1.5 Market by Application
1.5.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2025)
1.5.2 Academic & Clinical Research
1.5.3 Hospitals & Clinics
1.5.4 Pharma & Biotech Entities
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size
2.2 Clinical Oncology Next Generation Sequencing (NGS) Growth Trends by Regions
2.2.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions (2014-2025)
2.2.2 Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Manufacturers
3.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Manufacturers (2014-2019)
3.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI)
3.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players Head office and Area Served
3.3 Key Players Clinical Oncology Next Generation Sequencing (NGS) Product/Solution/Service
3.4 Date of Enter into Clinical Oncology Next Generation Sequencing (NGS) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019)
4.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019)
5 United States
5.1 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019)
5.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in United States
5.3 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
5.4 United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
6 Europe
6.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019)
6.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Europe
6.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
6.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
7 China
7.1 China Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019)
7.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in China
7.3 China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
7.4 China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
8 Japan
8.1 Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019)
8.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Japan
8.3 Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
8.4 Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019)
9.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Southeast Asia
9.3 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
9.4 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
10 India
10.1 India Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019)
10.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in India
10.3 India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
10.4 India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
11 Central & South America
11.1 Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size (2014-2019)
11.2 Clinical Oncology Next Generation Sequencing (NGS) Key Players in Central & South America
11.3 Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
11.4 Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
12 International Players Profiles
12.1 Illumina
12.1.1 Illumina Company Details
12.1.2 Company Description and Business Overview
12.1.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.1.4 Illumina Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.1.5 Illumina Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.2.4 Roche Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Agilent Technologies
12.3.1 Agilent Technologies Company Details
12.3.2 Company Description and Business Overview
12.3.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.3.4 Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.3.5 Agilent Technologies Recent Development
12.4 Knome
12.4.1 Knome Company Details
12.4.2 Company Description and Business Overview
12.4.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.4.4 Knome Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.4.5 Knome Recent Development
12.5 Genomatix Software
12.5.1 Genomatix Software Company Details
12.5.2 Company Description and Business Overview
12.5.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.5.4 Genomatix Software Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.5.5 Genomatix Software Recent Development
12.6 GATC Biotech
12.6.1 GATC Biotech Company Details
12.6.2 Company Description and Business Overview
12.6.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.6.4 GATC Biotech Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.6.5 GATC Biotech Recent Development
12.7 Oxford Nanopore Technologies
12.7.1 Oxford Nanopore Technologies Company Details
12.7.2 Company Description and Business Overview
12.7.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.7.4 Oxford Nanopore Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.7.5 Oxford Nanopore Technologies Recent Development
12.8 Macrogen
12.8.1 Macrogen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.8.4 Macrogen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.8.5 Macrogen Recent Development
12.9 Life Technologies
12.9.1 Life Technologies Company Details
12.9.2 Company Description and Business Overview
12.9.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.9.4 Life Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.9.5 Life Technologies Recent Development
12.10 DNASTAR
12.10.1 DNASTAR Company Details
12.10.2 Company Description and Business Overview
12.10.3 Clinical Oncology Next Generation Sequencing (NGS) Introduction
12.10.4 DNASTAR Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
12.10.5 DNASTAR Recent Development
12.11 Exosome Diagnostics
12.12 Biomatters
12.13 CLC Bio
12.14 BGI
12.15 Qiagen
12.16 Perkin Elmer
12.17 Pacific Bioscience
12.18 Partek
12.19 GnuBIO
12.20 Foundation Medicine
12.21 Paradigm
12.22 Caris Life Sciences
12.23 Myriad Genetics
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Clinical Oncology Next Generation Sequencing (NGS) Market Size, Status and Forecast 2019-2025
List of Tables and FiguresTable Clinical Oncology Next Generation Sequencing (NGS) Key Market Segments
Table Key Players Clinical Oncology Next Generation Sequencing (NGS) Covered
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type 2014-2025
Figure NGS Pre-Sequencing Figures
Table Key Players of NGS Pre-Sequencing
Figure Sequencing Figures
Table Key Players of Sequencing
Figure NGS Data Analysis Figures
Table Key Players of NGS Data Analysis
Figure Primary, Secondary & Tertiary Data Analysis Figures
Table Key Players of Primary, Secondary & Tertiary Data Analysis
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth by Application 2014-2025 (Million US$)
Figure Academic & Clinical Research Case Studies
Figure Hospitals & Clinics Case Studies
Figure Pharma & Biotech Entities Case Studies
Figure Clinical Oncology Next Generation Sequencing (NGS) Report Years Considered
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2025 (Million US$)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions 2014-2025 (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions 2014-2019 (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions 2014-2019
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions 2014-2019
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions 2019
Table Market Top Trends
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Manufacturers (2014-2019)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Manufacturers in 2018
Table Global Clinical Oncology Next Generation Sequencing (NGS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Clinical Oncology Next Generation Sequencing (NGS) Product/Solution/Service
Table Date of Enter into Clinical Oncology Next Generation Sequencing (NGS) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Type (2014-2019)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2014-2019)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Application (2014-2019)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2014-2019)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Application in 2018
Figure United States Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$)
Table United States Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$)
Table United States Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019)
Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$)
Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019)
Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table United States Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$)
Table Europe Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$)
Table Europe Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019)
Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$)
Table China Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$)
Table China Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019)
Table China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-20189) (Million US$)
Table China Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019)
Table China Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table China Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019)
Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$)
Table Japan Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$)
Table Japan Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019)
Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$)
Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019)
Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table Japan Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019)
Figure Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019)
Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019)
Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019)
Figure India Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$)
Table India Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$)
Table India Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019)
Table India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$)
Table India Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019)
Table India Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table India Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019)
Figure Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Clinical Oncology Next Generation Sequencing (NGS) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Clinical Oncology Next Generation Sequencing (NGS) Market Share (2018-2019)
Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type (2014-2019)
Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2019)
Table Illumina Company Details
Table Illumina Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019) (Million US$)
Figure Illumina Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Illumina Recent Development
Table Roche Company Details
Table Roche Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Roche Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure Agilent Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Agilent Technologies Recent Development
Table Knome Company Details
Table Knome Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure Knome Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Knome Recent Development
Table Genomatix Software Company Details
Table Genomatix Software Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure Genomatix Software Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Genomatix Software Recent Development
Table GATC Biotech Company Details
Table GATC Biotech Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure GATC Biotech Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table GATC Biotech Recent Development
Table Oxford Nanopore Technologies Company Details
Table Oxford Nanopore Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure Oxford Nanopore Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Oxford Nanopore Technologies Recent Development
Table Macrogen Company Details
Table Macrogen Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure Macrogen Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Macrogen Recent Development
Table Life Technologies Company Details
Table Life Technologies Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure Life Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table Life Technologies Recent Development
Table DNASTAR Company Details
Table DNASTAR Revenue in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)(Million US$)
Figure DNASTAR Revenue Growth Rate in Clinical Oncology Next Generation Sequencing (NGS) Business (2014-2019)
Table DNASTAR Recent Development
Table Exosome Diagnostics Company Details
Table Biomatters Company Details
Table CLC Bio Company Details
Table BGI Company Details
Table Qiagen Company Details
Table Perkin Elmer Company Details
Table Pacific Bioscience Company Details
Table Partek Company Details
Table GnuBIO Company Details
Table Foundation Medicine Company Details
Table Paradigm Company Details
Table Caris Life Sciences Company Details
Table Myriad Genetics Company Details
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions (Million US$) 2019-2025
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Regions (2019-2025)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Regions in 2025
Figure United States Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD)
Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD)
Figure India Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2019-2025)(Million USD)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Product (2019-2025) (Million US$)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Product (2019-2025)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Product in 2025
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2025) (Million US$)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2019-2025)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Clinical Oncology Next Generation Sequencing (NGS) Market Size, Status and Forecast 2019-2025
IlluminaRoche
Agilent Technologies
Knome
Genomatix Software
GATC Biotech
Oxford Nanopore Technologies
Macrogen
Life Technologies
DNASTAR
Exosome Diagnostics
Biomatters
CLC Bio
BGI
Qiagen
Perkin Elmer
Pacific Bioscience
Partek
GnuBIO
Foundation Medicine
Paradigm
Caris Life Sciences
Myriad Genetics
